Vitamin D in asthma and future perspectives

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 1003-1013

  Huang, Haidong ^a   Porpodis, Konstantinos ^b   Zarogoulidis, Paul ^b,c   Domvri, Kalliopi ^b   Giouleka, Paschalina ^b   Papaiwannou, Antonis ^b   Primikyri, Stella ^b   Mylonaki, Efi ^b   Spyratos, Dionysis ^b   Hohenforst Schmidt, Wolfgang ^d   Kioumis, Ioannis ^b   Zarogoulidis, Konstantinos ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c RUHRLANDKLINIK   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anti inflammation; Asthma; Immunomodulation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; ERGOSTEROL; PHOSPHATE; VITAMIN D; VITAMIN D RECEPTOR;

ASTHMA; CALCIUM METABOLISM; DISEASE ASSOCIATION; DISEASE MODEL; DNA POLYMORPHISM; EXPERIMENTAL ANIMAL; HEALTH; HUMAN; IMMUNITY; IN VITRO STUDY; LUNG DISEASE; LUNG FUNCTION; NONHUMAN; PHOSPHATE METABOLISM; RESPIRATORY HEALTH; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SKIN; SYNTHESIS; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SYNTHESIS;

ANTI-INFLAMMATION; ASTHMA; IMMUNOMODULATION; VITAMIN D;

ANIMALS; ASTHMA; CHILD; DIETARY SUPPLEMENTS; HUMANS; INFANT; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84884569070     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S50599     Document Type: Review

References (113)

1. Guidelines: GINA Report GSfAMaP. Global Initiative for Asthma (GINA). 2012. Available from http://www.ginasthma.org/documents/4. Accessed August 29, 2013.
2. Litonjua AA, Weiss ST. Is vitamin D defciency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120(5):1031-1035.
3. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D defciency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
4. Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc. 2010;110(10): 1492-1500.
5. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientifc statement. Endocr Rev. 2012;33(3):456-492.
6. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
7. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;(158):1-235.
8. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep). 2009;(183):1-420.
9. Sutherland ER, Goleva E, Jackson L P, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181(7):699-704.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D defciency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
11. Rosen CJ. Clinical practice. Vitamin D insuffciency. N Engl J Med. 2011;364(3):248-254.
12. Vieth R. Implications for 25-hydroxyvitamin D testing of public health policies about the benefts and risks of vitamin D fortifca-tion and supplementation. Scand J Clin Lab Invest Suppl. 2012;243: 144-153.
13. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384-390.
14. van Elden LJ, Sachs A P, van Loon AM, et al. Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. J Clin Virol. 2008;41(2): 116-121.
15. Borradale D, Kimlin M. Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin'. Nutr Res Rev. 2009;22(2):118-136.
16. Dixon KM, Tongkao-On W, Sequeira VB, et al. Vitamin d and death by sunshine. Int J Mol Sci. 2013;14(1):1964-1977.
17. Bossé Y, Lemire M, Poon AH, et al. Asthma and genes encoding components of the vitamin D pathway. Respir Res. 2009;10:98.
18. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more effciently than does vitamin D2. Am J Clin Nutr. 1998;68(4):854-858.
19. Romagnoli E, Mascia ML, Cipriani C, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015-3020.
20. Holick M F, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25- hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93(3): 677-681.
21. Biancuzzo RM, Young A, Bibuld D, et al. Fortifcation of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr. 2010;91(6): 1621-1626.
22. Rogers AJ, Raby BA, Lasky-Su JA, et al. Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Am J Respir Crit Care Med. 2009;179(12):1084-1090.
23. Pfeffer PE, Hawrylowicz CM. Vitamin D and lung disease. Thorax. 2012;67(11):1018-1020.
24. Hewison M, Freeman L, Hughes S V, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003;170(11):5382-5390.
25. Overbergh L, Decallonne B, Waer M, et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specifc T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes. 2000;49(8):1301-1307.
26. Wittke A, Weaver V, Mahon BD, August A, Cantorna MT. Vitamin D receptor-defcient mice fail to develop experimental allergic asthma. J Immunol. 2004;173(5):3432-3436.
27. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395-405.
28. Poon AH, Laprise C, Lemire M, et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med. 2004;170(9):967-973.
29. Raby BA, Lazarus R, Silverman EK, et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med. 2004;170(10):1057-1065.
30. Maalmi H, Sassi FH, Berraies A, Ammar J, Hamzaoui K, Hamzaoui A. Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: A case control study. Hum Immunol. 2013;74(2):234-240.
31. Fang WL, Gao LB, Liang WB, et al. Association analysis of vitamin D receptor gene polymorphisms in chinese population with asthma. Iran J Allergy Asthma Immunol. 2009;8(3):141-147.
32. Li F, Jiang L, Willis-Owen SA, Zhang Y, Gao J. Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet. 2011;12:103.
33. Pillai DK, Iqbal SF, Benton AS, et al. Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study. J Investig Med. 2011;59(6): 938-946.
34. Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011;11(1):29-36.
35. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, infammation and the allergic response-The role of glucocorticoids and Vitamin D. J Steroid Biochem Mol Biol. 2010;120(2-3):86-95.
36. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116(1):146-155.
37. Banerjee A, Damera G, Bhandare R, et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol. 2008;155(1):84-92.
38. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal infu-enza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255-1260.
39. Brunetti L, Colazzo D, Francavilla R, et al. The role of pulmonary infection in pediatric asthma. Allergy Asthma Proc. 2007;28(2):190-193.
40. Ginde AA, Mansbach JM, Camargo CA Jr. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep. 2009;9(1):81-87.
41. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179(4):2060-2063.
42. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4(2):80-90.
43. Damera G, Fogle H W, Lim P, et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol. 2009;158(6):1429-1441.
44. Iqbal SF, Freishtat RJ. Mechanism of action of vitamin D in the asthmatic lung. J Investig Med. 2011;59(8):1200-1202.
45. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88(5):441-450.
46. Wang TT, Nestel F P, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-2912.
47. McKeever TM, Britton J. Diet and asthma. Am J Respir Crit Care Med. 2004;170(7):725-729.
48. Lee JM, Smith JR, Philipp BL, Chen TC, Mathieu J, Holick M F. Vitamin D defciency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila). 2007;46(1):42-44.
49. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D defciency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158(6):531-537.
50. Moore CE, Murphy MM, Holick M F. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr. 2005;135(10):2478-2485.
51. Pinto JM, Schneider J, Perez R, DeTineo M, Baroody FM, Naclerio RM. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol. 2008;122(2):415-417.
52. Gale CR, Robinson SM, Harvey NC, et al; Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr. 2008;62(1):68-77.
53. Gern JE, Lemanske RF Jr, Busse W.W. Early life origins of asthma. J Clin Invest. 1999;104(7):837-843.
54. Warner JA, Jones CA, Jones AC, Warner JO. Prenatal origins of allergic disease. J Allergy Clin Immunol. 2000;105(2 Pt 2):S493-S498.
55. Devereux G. Maternal diet during pregnancy: an emerging risk factor for childhood asthma. Expert Rev Clin Immunol. 2008;4(6): 663-668.
56. Martindale S, McNeill G, Devereux G, Campbell D, Russell G, Seaton A. Antioxidant intake in pregnancy in relation to wheeze and eczema in the frst two years of life. Am J Respir Crit Care Med. 2005;171(2): 121-128.
57. Devereux G, Turner S W, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med. 2006;174(5):499-507.
58. Litonjua AA, Rifas-Shiman SL, Ly N P, et al. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006;84(4):903-911.
59. Devereux G, Litonjua AA, Turner S W, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85(3):853-859.
60. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85(3):788-795.
61. Willers SM, Devereux G, Craig LC, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax. 2007;62(9):773-779.
62. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39(6):875-882.
63. Javaid MK, Crozier SR, Harvey NC, et al; Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006;367(9504): 36-43.
64. Hollis B W, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovita-minosis D for both the mother and the nursing infant. Am J Clin Nutr. 2004;80(6 Suppl):1752S-1758S.
65. Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. Rep Health Soc Subj (Lond). 1991;41:1-210. [No authors listed].
66. Hollis B W, Wagner CL. Nutritional vitamin D status during pregnancy: reasons for concern. CMAJ. 2006;174(9):1287-1290.
67. Hyppönen E, Sovio U, Wjst M, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci. 2004;1037:84-95.
68. Bäck O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol. 2009;89(1):28-32.
69. Kull I, Bergström A, Melén E, et al. Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J Allergy Clin Immunol. 2006;118(6): 1299-1304.
70. Holick M F. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
71. Hollis B W, Pittard WB 3rd. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab. 1984;59(4):652-657.
72. Camargo CA Jr, Ingham T, Wickens K, et al; New Zealand Asthma and Allergy Cohort Study Group. Vitamin D status of newborns in New Zealand. Br J Nutr. 2010;104(7):1051-1057.
73. Carroll KN, Gebretsadik T, Larkin EK, et al. Relationship of maternal vitamin D level with maternal and infant respiratory disease. Am J Obstet Gynecol. 2011;205(3):215. e1-e7.
74. Camargo CA Jr, Ingham T, Wickens K, et al; New Zealand Asthma and Allergy Cohort Study Group. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180-e187.
75. Algert CS, Bowen JR, Lain SL, Allen HD, Vivian-Taylor JM, Roberts CL. Pregnancy exposures and risk of childhood asthma admission in a population birth cohort. Pediatr Allergy Immunol. 2011;22(8):836-842.
76. Morales E, Romieu I, Guerra S, et al; INMA Project. Maternal vitamin D status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring. Epidemiology. 2012;23(1):64-71.
77. Pike KC, Inskip HM, Robinson S, et al; Southampton Women's Survey Study Group. Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes. Thorax. 2012; 67(11):950-956.
78. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-478.
79. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ. 2002;51(1):1-13.
80. Kunisaki KM, Niewoehner DE, Connett JE; COPD Clinical Research Network. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(3):286-290.
81. Machura E, Brus R, Kalacinński W, Lacheta M. The effect of dietary fsh oil supplementation on the clinical course of asthma in children. Pediatr Pol. 1996;71(2):97-102. Polish [with English abstract].
82. Brehm JM, Celedón JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179(9):765-771.
83. Brehm JM, Schuemann B, Fuhlbrigge AL, et al; Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126(1):52-58. e5.
84. Brehm JM, Acosta-Pérez E, Klei L, et al. Vitamin D insuffciency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med. 2012;186(2):140-146.
85. Freishtat RJ, Iqbal SF, Pillai DK, et al. High prevalence of vitamin D defciency among inner-city African American youth with asthma in Washington, DC. J Pediatr. 2010;156(6):948-952.
86. Arnedo-Pena A, García-Marcos L, Fernández-Espinar J F, et al. Sunny hours and variations in the prevalence of asthma in schoolchildren according to the International Study of Asthma and Allergies (ISAAC) Phase III in Spain. Int J Biometeorol. 2011;55(3):423-434.
87. Chinellato I, Piazza M, Sandri M, Peroni D, Piacentini G, Boner AL. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr. 2011;158(3):437-441.
88. Hughes AM, Lucas RM, Ponsonby AL, et al. The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study. Pediatr Allergy Immunol. 2011;22(3):327-333.
89. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127(5): 1294-1296.
90. Alyasin S, Momen T, Kashef S, Alipour A, Amin R. The relationship between serum 25 hydroxy vitamin d levels and asthma in children. Allergy Asthma Immunol Res. 2011;3(4):251-255.
91. Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D defciency as a strong predictor of asthma in children. Int Arch Allergy Immunol. 2012;157(2):168-175.
92. Goleva E, Searing DA, Jackson L P, Richers BN, Leung DY. Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol. 2012; 129(5):1243-1251.
93. Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125(5):995-1000.
94. Schou AJ, Heuck C, Wolthers OD. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover? Pediatr Pulmonol. 2003;36(5): 399-404.
95. Majak P, Rychlik B, Stelmach I. The effect of oral steroids with and without vitamin D3 on early effcacy of immunotherapy in asthmatic children. Clin Exp Allergy. 2009;39(12):1830-1841.
96. Wu AC, Tantisira K, Li L, Fuhlbrigge AL, Weiss ST, Litonjua A; Childhood Asthma Management Program Research Group. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med. 2012;186(6):508-513.
97. Tse SM, Kelly H W, Litonjua AA, Va n Natta ML, Weiss ST, Tantisira KG; Childhood Asthma Management Program Research Group. Corticosteroid use and bone mineral accretion in children with asthma: effect modifcation by vitamin D. J Allergy Clin Immunol. 2012;130(1):53-60. e4.
98. Utz G, Hauck AM. Oral application of calcium and vitamin D2 in allergic bronchial asthma (author's transl). MMW Munch Med Wochenschr. 1976;118(43):1395-1398. German [with English abstract].
99. Worth H, Stammen D, Keck E. Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate. Am J Respir Crit Care Med. 1994;150(2):394-397.
100. Ememl'ianov AV, Shevelev SE, Murzin BA, Amosov VI. Effciency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma. Ter Arkh. 1999;71(11):68-69. Russian [with English abstract].
101. Li F, Peng M, Jiang L, et al. Vitamin D defciency is associated with decreased lung function in Chinese adults with asthma. Respiration. 2011;81(6):469-475.
102. Varney VA, Evans J, Bansal AS. Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D. J Asthma Allergy. 2011;4:87-91.
103. Gruber HE, Hoelscher G, Ingram JA, Chow Y, Loeffler B, Hanley EN Jr. 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro. Spine (Phila Pa 1976). 2008;33(7):755-765.
104. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T. 1alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis. 2005;26(2):429-440.
105. Kim SH, Choi GS, Nam YH, et al. Role of vitamin D-binding protein in isocyanate-induced occupational asthma. Exp Mol Med. 2012;44(5):319-329.
106. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792-3798.
107. Shaheen SO, Jameson KA, Robinson SM, et al. Relationship of vitamin D status to adult lung function and COPD. Thorax. 2011;66(8):692-698.
108. Lee J, Zhao H, Fenta Y, Kita H, Kumar R, Juhn YJ. Serum 25-hydroxyvi-tamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma. Allergy Asthma Proc. 2011;32(6):445-452.
109. Wjst M, Dold S. Genes, factor X, and allergens: what causes allergic diseases? Allerg y. 1999;54(7):757-759.
110. Weiss ST, Litonjua AA. Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases. Thorax. 2007;62(9):746-748.
111. Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CA Jr. Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013;110(4):240-246. e1.
112. Litonjua AA. Vitamin D and corticosteroids in asthma: synergy, interaction and potential therapeutic effects. Expert Rev Respir Med. 2013;7(2):101-104.
113. Lappe JM, Heaney R P. Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol. 2012;4(2): 95-100.